Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.
about
Side effects of yttrium-90 radioembolizationTransarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsYttrium-90 radioembolization of liver tumors: what do the images tell us?Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesX-ray-induced shortwave infrared biomedical imaging using rare-earth nanoprobes.Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaRare Earth Nanoprobes for Functional Biomolecular Imaging and Theranostics.Temporary arterial balloon occlusion as an adjunct to Yttrium-90 radioembolization.Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Rare-earth-doped biological composites as in vivo shortwave infrared reportersUsefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors.Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following intratumoral injection.Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseA low-interaction automatic 3D liver segmentation method using computed tomography for selective internal radiation therapy.Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trialPositron emission tomography image-guided drug delivery: current status and future perspectives.Embolotherapy in the management of hepatocellular carcinoma.[90Y]yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases"What goes round comes round"Prophylactic embolization of the cystic artery before radioembolization: feasibility, safety, and outcomes.Research reporting standards for radioembolization of hepatic malignancies.Technical solutions to ensure safe yttrium-90 radioembolization in patients with initial extrahepatic deposition of (99m)technetium-albumin macroaggregatesRadioembolization for primary and metastatic liver cancer.Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat StudiesCeliac artery stenting to facilitate hepatic yttrium-90 radioembolization therapy.Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs.A review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy.Selective Arterial Embolization of Liver Metastases from Gastrinomas: A Single-Centre Experience.Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical reviewRadionuclide carriers for targeting of cancer.Y-90 microshperes in the treatment of unresectable hepatocellular carcinoma.Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery.
P2860
Q26821887-C761F964-B1FA-4189-A735-BE19B6FEE23AQ26852174-DD6CC0AE-46A6-460B-8ECB-16F0E139AEFEQ26997064-52919EF6-6D5C-4C2F-9B71-2E9E83F1402DQ27023616-EA0BE4F0-EA90-45BF-9737-C354CF6547C5Q27335168-D69BCC15-5852-4DC7-A89F-4453900D21ABQ28314897-E05B2114-1ADF-46CF-9EE9-94BC7AAB949BQ30410841-9B212729-5E32-472F-9892-4E4389F8086EQ30456316-CFE97591-62F4-46A9-B51C-CFB1821C9E21Q30468280-A5023DB0-D841-4E18-A741-5ED56D8CAFB4Q30542410-7D5FF678-75D4-41A8-A8AB-A9655CDC9731Q33704156-D40ECD84-01C9-417A-8C3B-D724D35D8060Q33715683-72CF2A87-DCA9-4DB2-8C6E-21F07F9D666BQ33851393-548201C5-4DC5-457D-8F81-A56627D71E92Q33870879-2C721486-AB49-425B-9680-44CFBE4E5618Q33930392-8C2EF6E8-7F33-43D3-A580-5706B8A48638Q33991842-AC6B132D-F50B-4336-A759-CFE3AAE60F8EQ34446108-53F719BF-6A67-4B56-904A-06FD04EAC42BQ34563655-3542FFB3-DBA5-47A4-8224-4F4B80B99785Q34866445-6695A187-9EBB-4AA8-9CFB-1DCDBE4E477CQ34991326-BA161D9E-3C95-4216-8E80-424274A76A22Q35094057-1F9118C3-EC88-4AE0-93EE-B440ECE78241Q35111887-A655F33A-CD9D-42AE-80CF-40C42182B460Q35206768-EF233C9F-EA83-4DD5-8ED0-FD8F889E886CQ35564038-6E8BC091-16B3-4865-9952-15F93B4132E5Q35658025-2A5142F9-7230-4AC1-92F8-61BBECBB3362Q35721324-A617194E-056B-4B6B-9BB7-8823B5B34020Q36062588-A6B90364-0A0F-4B10-902C-8ACB0481DF0AQ36163785-9FC09F29-EE4C-4F87-AF7A-289C2017C04CQ36470428-A2846E41-DE79-4A3D-A904-EAA331A70F6BQ36482781-0CDE56EE-043A-4898-A8FA-DE16C0F8FB0BQ36728823-0FDAFBA4-CA17-42D5-905D-F98AECF96FB7Q36738344-F58CC97C-69A5-44A7-8971-2AA3469D4E5AQ36899620-17D47D61-730A-41AD-BABB-B476F257E18BQ36961922-2A748556-D35C-411A-A38C-C982852FBE20Q36980633-DC6F1FCE-4692-4B39-8B44-1049E934FE9BQ37113543-54C66EAD-C0F1-4C3C-8452-BE70FA9B5540Q37237705-BB45D876-8637-4077-B7EF-7F791A7AE046Q37243546-83904B19-389F-44F8-9791-FB6A55706DEDQ37326857-E62ADD6F-466A-434F-803E-8ADFC6D8594CQ37353096-BC28B26F-0E44-4788-930E-2E2FF0EEF555
P2860
Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Yttrium-90 microsphere therapy ...... , and potential complications.
@ast
Yttrium-90 microsphere therapy ...... , and potential complications.
@en
type
label
Yttrium-90 microsphere therapy ...... , and potential complications.
@ast
Yttrium-90 microsphere therapy ...... , and potential complications.
@en
prefLabel
Yttrium-90 microsphere therapy ...... , and potential complications.
@ast
Yttrium-90 microsphere therapy ...... , and potential complications.
@en
P2093
P356
P1433
P1476
Yttrium-90 microsphere therapy ...... , and potential complications.
@en
P2093
Alan Cohen
Andrew S Kennedy
David C Madoff
Douglas M Coldwell
Janio Szklaruk
Kamran Ahrar
Marshall E Hicks
Michael J Wallace
Ravi Murthy
Rodolfo Nunez
P304
P356
10.1148/RG.25SI055515
P478
25 Suppl 1
P577
2005-10-01T00:00:00Z